The Department of Veterans Affairs has selected Abridge for an enterprise-wide ambient AI scribe contract with a five-year ceiling of $775.72 million across all eligible vendors, expanding a technology already deployed at roughly 70 VA medical centers.
OpenAI announced on September 1 that ChatGPT for Healthcare now connects directly to Epic's electronic health record system, with UCSF Health piloting the read-only integration alongside a new plugin linking ChatGPT to nine public health databases.
Sanofi has entered a worldwide strategic licensing agreement with ScionxBio to access an AI-designed mRNA technology platform, extending the AI drug discovery wave into messenger RNA therapeutics.
AstraZeneca is working with startup Tremont AI to build AI models that flag potentially toxic drug candidates earlier in development, aiming to cut the cost and time lost to late-stage trial failures.
Personalis shareholders of record as of October 15 will soon vote on Tempus AI's all-stock acquisition, a deal that would fold Personalis' cancer genomics testing into Tempus' AI-driven oncology data platform.
A Lancet-published study of an AI system handling direct patient interactions in primary care reported no safety-related stops across 114 patients, a notable milestone for AI deployed in frontline clinical settings.
The American Nurses Association has named a vice president of AI and Digital Health Programs to lead a three-year initiative backed by Johnson & Johnson Foundation and Google.org funding.
Eli Lilly signed a roughly $1.1 billion AI drug delivery deal, separate from its earlier Insilico discovery partnership, extending AI across its pipeline.
Abridge closed a $316 million funding extension and added Eli Lilly as a strategic investor, pushing its AI scribe business deeper into billing automation.
Daniel Ek's Neko Health raised $700 million and opened its first US clinic in SoHo, betting that consumers will pay out of pocket for AI-driven preventive body scans.